76
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0009 |
UCB9608
|
PI4K | PI3K/Akt/mTOR signaling |
UCB9608 是选择性、可口服的 PI4KIIIβ 抑制剂,IC50=11 nM,对其选择性高于 PI3KC2 α,β 和 γ。它能够增加代谢稳定性,具有良好的药代动力学特征,是一种免疫抑制剂。 | |||
T27499 |
GSK-A1
|
HCV Protease; PI4K | Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
GSK-A1 是 III 型磷脂酰肌醇 4-激酶 PI4KA 选择性抑制剂,pIC50为 8.5-9.8,抑制 PtdIns(4,5)P2 再合成,IC50约为 3 nM。GSK-A1有效降低 PtdIns(4)P 的水平,而对 PtdIns(4,5)P2 没影响。GSK-A1在抗丙型肝炎病毒方面有研究的潜力。 | |||
T13386 |
Zandelisib
|
PI3K | PI3K/Akt/mTOR signaling |
Zandelisib 是PI3K 抑制剂,对p110δ选择性抑制,IC50为 3.5 nM。它显示出抗肿瘤作用。 | |||
T16125 |
MMV390048
|
Parasite; PI4K | Microbiology/Virology; PI3K/Akt/mTOR signaling |
MMV390048 是一种抗疟药,是一种新型化学疟原虫 PI4K 抑制剂。它与疟原虫 PI4K 的 ATP 结合位点结合,不与除人类 PIP4K2C 外的其他恶性疟原虫和人类激酶结合。 | |||
T16967 |
T-00127_HEV1
|
PI4K | PI3K/Akt/mTOR signaling |
T-00127_HEV1 是有效的phosphatidylinositol 4-kinase III beta 抑制剂,IC50为 60 nM。 | |||
T12454 |
PI-273
|
Apoptosis; PI4K | Apoptosis; PI3K/Akt/mTOR signaling |
PI-273 是一种可逆的特异性磷脂酰肌醇 4-激酶抑制剂,IC50为 0.47 μM。它可抑制乳腺癌细胞的增殖,阻断细胞周期并诱导细胞凋亡。 | |||
T16530 |
BF738735
|
Antiviral; PI4K | Immunology/Inflammation; PI3K/Akt/mTOR signaling |
BF738735 是有效的磷脂酰肌醇 4-激酶 IIIβ 抑制剂,IC50为 5.7 nM。 | |||
T5421 |
KDU691
|
Parasite; PI4K | Microbiology/Virology; PI3K/Akt/mTOR signaling |
KDU691 是一种咪唑吡嗪类药物,对血阶段的裂殖体、配子体和肝期具有较强的抗寄生虫活性,它是 PI4K 抑制剂,选择性抑制双氢青蒿素预处理的恶性疟原虫。 | |||
T12468 |
PI4KIIIbeta-IN-10
|
PI3K; PI4K | PI3K/Akt/mTOR signaling |
PI4KIIIbeta-IN-10 是PI4KIIIβ抑制剂,IC50=3.6 nM。 | |||
T2616 |
PIK-93
PIK 93 |
ATM/ATR; DNA-PK; Virus Protease; PI3K; Carbonic Anhydrase; PI4K; mTOR; HSV | DNA Damage/DNA Repair; Metabolism; Microbiology/Virology; PI3K/Akt/mTOR signaling |
PIK-93 是一种合成的PI4KIIIβ抑制剂,IC50值为 19 nM,同时可抑制PI3Kγ和PI3Kα的活性,IC50值分别为 16 nM 和 39 nM。 | |||
T12469 |
PI4KIIIbeta-IN-9
|
PI3K; PI4K | PI3K/Akt/mTOR signaling |
PI4KIIIbeta-IN-9 是一种 PI4KIIIβ抑制剂,其 IC50=7 nM。它也抑制 PI3Kδ (IC50:125 nM) 和 PI3Kγ (IC50:1046 nM)。 | |||
T4220 |
BQR-695
BQR695,NVP-BQR695 |
PI3K; Parasite; PI4K | Microbiology/Virology; PI3K/Akt/mTOR signaling |
BQR-695 (NVP-BQR695) 是一种磷脂酰肌醇 4-激酶抑制剂,对于人类和疟原虫 PI4KIIIβ 的 IC50值分别为 80 和 3.5 nM。 | |||
T19840 |
GSK-F1
PI4KA inhibitor-F1 |
PI4K | PI3K/Akt/mTOR signaling |
GSK-F1 (PI4KA inhibitor-F1) 是一种新型强效 PI4KA 抑制剂。 | |||
T4079 |
LY-294002 hydrochloride
SF 1101,LY 294002,NSC 697286 |
PI3K | PI3K/Akt/mTOR signaling |
LY-294002 hydrochloride (NSC 697286) 是一种合成的 PI3Kα/δ/β 分子抑制剂(IC50:0.5/0.57/0.97 μM,在无细胞试验中);在溶液中比 Wortmannin 更稳定,也是自噬体形成的阻断剂。 | |||
T41270 |
Phosphatidylinositols, soya, sodium salts
|
||
Phosphatidylinositols, soya, sodium salts 在生命科学相关研究中具有广泛的应用。 | |||
T77212 |
L-α-lysophosphatidylinositol (Soy) (sodium)
|
||
L-α-lysophosphatidylinositol Soy sodium 作为GPR55的内源性配体,是一种既属于内源性溶血磷脂也是内源性大麻素神经递质的化合物。 | |||
T28416 |
PIK-108
PIK 108,PIK108 |
PI3K | PI3K/Akt/mTOR signaling |
PIK-108 是选择性的、变构的、非 ATP 竞争性的 p110β/p110δ 抑制剂。 | |||
T2061 |
APY0201
|
PI3K; Interleukin | Immunology/Inflammation; PI3K/Akt/mTOR signaling |
APY0201 是PIKfyve 抑制剂,能够抑制 PtdIns3P 转化为PtdIns(3,5)P2 (IC50:5.2 nM),还能够抑制IL-12/IL-23产生。 | |||
T26195 |
SMI481
NPPM-6748-481,NPPM 6748-481,NPPM6748481,SMI-481 SMI 481,NPPM 6748481 |
Others | Others |
SMI481 (NPPM6748481) 是一种选择性的酵母磷脂酰肌醇转移蛋白 (PITP) Sec14 抑制剂。 | |||
T67837 |
(3S)-GSK-F1
PI4KA inhibitor-F1 |
PI4K | PI3K/Akt/mTOR signaling |
(3S)-GSK-F1是一种选择性PI4KIIIα抑制剂,pIC50=8.3。 | |||
T3556 |
NIH-12848
|
PI3K | PI3K/Akt/mTOR signaling |
NIH12848 是推定的磷脂酰肌醇 5-磷酸4-激酶 γ (PI5P4Kγ) 抑制剂(IC50:1 μM)。 | |||
T12365 |
PARP/PI3K-IN-1
|
PARP; PI3K | Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
PARP/PI3K-IN-1 是一种 新型双重聚(ADP-核糖)聚合酶(PARP)和磷酸肌醇 3-激酶(PI3K)双重抑制剂,具有抗癌、抗肿瘤和抗癌细胞增殖活性,可用于研究乳腺癌、胰腺癌和肺癌。 | |||
T26698 |
AZ044
|
PI4K | PI3K/Akt/mTOR signaling |
AZ044是 III 型磷脂酰肌醇-4-激酶α -亚型(PI4KIIIalpha)的有效选择性抑制剂。 | |||
T16528 |
PI-828
LY 294002, 4gamma-NH2 |
Casein Kinase; PI3K | Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
PI-828 是磷脂酰肌醇3-激酶(PI3K)抑制剂,广泛用于研究 PI3K 的生理功能,也可促进干细胞向中胚层分化。 | |||
T1861 |
Omipalisib
GSK458,GSK2126458 |
PI3K; mTOR; Autophagy | Autophagy; PI3K/Akt/mTOR signaling |
Omipalisib (GSK2126458) 是一种磷脂酰肌醇 3-激酶(PI3K) 的小分子吡啶磺酰胺抑制剂,具有抗肿瘤活性。它抑制 p110α/β/δ/γ,mTORC1/2 的活性,Ki 值分别为 0.019 nM/0.13 nM/0.024 nM/0.06 nM 和 0.18 nM/0.3 nM。 | |||
T6168 |
ZSTK474
|
PI3K; Autophagy | Autophagy; PI3K/Akt/mTOR signaling |
ZSTK474 是 ATP 竞争性的泛 I 类PI3K 抑制剂,抑制 PI3Kα、PI3Kβ、PI3Kδ 和 PI3Kγ,IC50分别为 16 nM、44 nM、4.6 nM 和 49 nM。它是一种可口服的 s-三嗪衍生物,具有抗肿瘤活性。 | |||
T1999 |
Taselisib
RG-7604,GDC-0032 |
PI3K; Carbonic Anhydrase | Metabolism; PI3K/Akt/mTOR signaling |
Taselisib (GDC-0032) 是 PI3K 抑制剂,靶向作用于突变 PI3KCA。它能够抑制 PI3Kα (IC50:0.29 nM),PI3Kβ (IC50:0.91 nM) 和 PI3Kγ (IC50:0.97 nM)。 | |||
T67845 |
ARUK2001607
|
PI3K | PI3K/Akt/mTOR signaling |
ARUK2001607 是磷脂酰肌醇 5-磷酸 4-激酶 γ (PI5P4Kγ) 的选择性抑制剂,Kd 为 7.1 nM。ARUK2001607 对PI5P4Kγ的选择性超过其他 >150 种激酶。 | |||
T13623 |
Compound 48/80 trihydrochloride
C48/80 trihydrochloride |
Phospholipase | Metabolism |
Compound 48/80 trihydrochloride (C48/80 trihydrochloride) 是 N-甲基对甲氧基苯乙胺和甲醛发生缩合反应后的混合物。Compound 48/80 trihydrochloride 是一种肥大细胞 (mast cell) 脱颗粒剂和组胺 (histamine) 释放剂。Compound 48/80 trihydrochloride 对人血小板磷脂酰肌醇特异性磷脂酶 C (phosphatidylinositol-specific phospholipase C) 活性有抑制作用。 | |||
T27094 |
CT-2584
CT2584 |
||
CT-2584 is an angiogenesis inhibitor and lysophosphatidic acid acyltransferase inhibitor. CT-2584 inhibits phospholipid signaling. By inhibiting CTP:choline-phosphate cytidylyltransferase (CT), CT-2584 caused de novo phospholipid biosynthesis via PA to be | |||
T68130 |
Pobilukast
SKF 104353 Z2,SKF 104353 |
Leukotriene Receptor | GPCR/G Protein |
Pobilukast (SKF 104353) 是一种选择性半胱氨酰白三烯受体拮抗剂,可阻断磷脂酰肌醇代谢和白三烯D诱导的血栓素合成,可用于研究过度心肌再灌注损伤 (MI/R) 大鼠限制心肌损伤。 | |||
T2370 |
AC-55541
AOB2796 |
Proteasome; Protease-activated Receptor | GPCR/G Protein; Proteases/Proteasome; Ubiquitination |
AC-55541 (AOB2796) 是高选择性的蛋白酶激活受体 2(PAR2)激动剂,pEC50为6.7。它在 PI 水解测定和 Ca2+动态测定中的pEC50值为 5.9 和 6.6,在体内表现出伤害感受器活性。 | |||
T72032 |
PI5P4Ks-IN-2
|
PI3K | PI3K/Akt/mTOR signaling |
PI5P4Ks-IN-2 是磷脂酰肌醇 5-磷酸 4-激酶 PI5P4Kγ 的抑制剂。PI5P4Ks-IN-2 靶向 PI5P4K 亚型,对 PI5P4Kα、PI5P4Kβ、PI5P4Kγ和PI5P4Kγ+具有抑制作用 ,IC50 值分别 <4.3、<4.6、6.2和0.32 。 | |||
T67703 |
mTOR inhibitor 9b
|
mTOR | PI3K/Akt/mTOR signaling |
mTOR inhibitor 9b 是一种酶抑制剂,对蛋白激酶mTOR 和磷脂酰肌醇 3-激酶 PIK3CA 具有抑制作用,IC50分别为 0.76nm 和1.262 µM。mTOR inhibitor 9b 具有抗癌活性,可用来研究白血病、皮肤癌、乳腺癌、肺癌和结肠癌。 | |||
T36083 |
DS-7423
|
PI3K; mTOR | PI3K/Akt/mTOR signaling |
DS-7423 是PI3K 和mTOR 的有效抑制剂,抑制PI3Kα 和 mTOR 的IC50分别为15.6 nM 和 34.9 nM。DS-7423表现出抗癌活性。 | |||
T67702 |
mTOR inhibitor 9d
|
PI3K; mTOR | PI3K/Akt/mTOR signaling |
mTOR inhibitor 9d 是一种蛋白激酶 mTOR 和PI3K 双重抑制剂,对mTOR 的IC50值为0.31nm,可用于治疗白血病、皮肤癌、乳腺癌、肺癌和结肠癌。 | |||
T32950 |
Lumi-PI
|
||
Lumi-PI is used as a chemiluminescent substrate for detecting phosphatidylinositol-specific phospholipase C. | |||
T69912 |
AS2541019
|
||
AS2541019 is a selective Phosphatidylinositol-3-kinase p110δ (PI3Kδ) inhibitor. | |||
T39581 |
PI3K-IN-19 hydrochloride
PI3K-IN-19 hydrochloride |
||
PI3K-IN-19 hydrochloride (WO2017153220, step 5) acts as a phosphatidylinositol-3-kinase (PI3K) inhibitor. | |||
T22759 | Edelfosine | Others | Others |
inhibits phosphatidylinositol phospholipase C | |||
T24637 |
PI3K inhibitor C 96
PI3K IN C96,PI3K-IN-C96 |
||
PI3K inhibitor C 96 is an inhibitor of phosphatidylinositol 3-kinase. It shows effective activity against multiple myeloma in vitro and in vivo. | |||
T71798 |
Demethoxyviridiol
|
||
Demethoxyviridiol is a mycotoxin that inhibits phosphatidylinositol 3-kinase (PI3K). | |||
T27526 |
Halenaquinone
|
||
Halenaquinone is a phosphatidylinositol 3-kinase inhibitor. Halenaquinone specifically inhibits the secondary DNA binding of RAD51. Halenaquinone inhibits RANKL-induced osteoclastogenesis. Halenaquinone induces apoptosis in PC12 cells. | |||
T28627 |
RV-1729
RV1729 |
||
RV-1729, a phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) inhibitor, is used potentially for the treatment of asthma. | |||
T29159 |
WJD008
WJD-008,WJD 008 |
||
WJD008 is a dual inhibitor of phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin. WJD008 prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant. WJD008 has antiproliferative and anticlonogeni | |||
TP1977 |
187-1, N-WASP inhibitor
|
||
Inhibits neural Wiskott-Aldrich syndrome protein (N-WASP) by stabilizing the autoinhibited state of the protein. Blocks phosphatidylinositol 4,5-bisphosphate (PIP2)-stimulated actin assembly (IC50 ~ 2 μM) but does not directly inhibit actin polymerization | |||
T37030 |
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt)
PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) |
||
The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(4)-P1 (1,2-dioctanoyl) is a synthetic analog of natural phosphatidylinositol (PtdIns) featuring C8:0 fatty acids at the sn-1 and sn-2 positions. The compound contains the same inositol and diacylglycerol (DAG) stereochemistry as the natural compound. PtdIns-(4)-P1 can be phosphorylated to di- ... | |||
T27157 |
Dezapelisib
INCB-040093,INCB 040093,INCB040093 |
||
Dezapelisib is an orally bioavailable, selective inhibitor of the delta isoform of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinases (PI3K). INCB040093 prevents both the production of the second messenger phosphatidylinositol-3,4,5-trisp | |||
T36937 |
PtdIns-(1,2-dioctanoyl) (sodium salt)
|
||
The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(1,2-dioctanoyl) is a synthetic analog of natural phosphatidylinositol (PtdIns) containing C8:0 fatty acids at the sn-1 and sn-2 positions. The compound features the same inositol and diacyl glycerol (DAG) stereochemistry as that of the natural compound. The short fatty acid chains of this anal... | |||
T4186 |
AC-264613
AC264613 |
Protease-activated Receptor | GPCR/G Protein |
AC-264613 是一种选择性蛋白酶激活受体 (PAR-2) 激动剂,pEC50为 7.5。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73812 |
Phosphatidylinositol 4,5-bisphosphate
|
||
Phosphatidylinositol 4,5-bisphosphate(L-alpha-Phosphatidylinositol-4,5-bisphosphate)为细胞膜磷脂成分,主要作为磷脂酶C(PLC)与磷酸肌醇3-激酶(PI3K)的底物,充当重要信使。 | |||
T3399 |
Psoralidin
|
Others; Estrogen/progestogen Receptor; Reactive Oxygen Species; Lipoxygenase; Gamma-secretase; Akt; COX; Antibacterial | Cytoskeletal Signaling; Endocrinology/Hormones; Immunology/Inflammation; Metabolism; Microbiology/Virology; Neuroscience; NF-κB; Others; PI3K/Akt/mTOR signaling; Proteases/Proteasome; Stem Cells |
Psoralidin 是COX-2和5-LOX 的抑制剂,有抗癌,抗菌和抗炎作用。它显著下调NOTCH1信号传导,还极大地诱导活化氧产生。 | |||
TN2019 |
Orobol
3'-Hydroxygenistein,3’,4’,5,7-tetrahydroxy-isoflavon,3',4',5,7-四羟基异黄酮 |
BCL; Caspase; PI3K | Apoptosis; PI3K/Akt/mTOR signaling; Proteases/Proteasome |
Orobol (3’,4’,5,7-tetrahydroxy-isoflavon) 是酪氨酸特异性蛋白激酶和磷脂酰肌醇转换的抑制剂。Orobol 抑制 PI3K,对 PI3K α/β/γ/K/δ 的 IC50 为 3.46-5.27 μM。 Orobol 具有抗皮肤老化和抗肥胖的作用。 | |||
T4S21320 |
ISOGINKGETIN
异银杏素,4',4'''-Dimethylamentoflavone,异银杏双黄酮 |
MMP; Others | Others; Proteases/Proteasome |
ISOGINKGETIN (4',4'''-Dimethylamentoflavone) 是一种MMP9抑制剂,也是一种Pre-mRNA Splicing 抑制剂。 | |||
TMA0291 | Dehydroglyasperin D | GSK-3; p38 MAPK; ROS; Akt; COX; PI3K; DNA/RNA Synthesis; Prostaglandin Receptor; JNK | Cell Cycle/Checkpoint; Cytoskeletal Signaling; DNA Damage/DNA Repair; GPCR/G Protein; Immunology/Inflammation; MAPK; Neuroscience; PI3K/Akt/mTOR signaling; Stem Cells |
Dehydroglyasperin D exhibits anticancer, anti-inflammatory, anti-obesity, antioxidant and anti-aldose reductase effects, it inhibits the proliferation of HT-29 human colorectal cancer cells through direct interaction with phosphatidylinositol 3-kinase; it also mediates suppression of both COX-2 expression and the MLK3 signalling pathway through direct binding and inhibition of MLK3. Dehydroglyasperin D shows strong ferric reducing activities and effectively scavenged DPPH, ABTS(+), and singlet o... |